PLAID RX Trademark

Trademark Overview

On Thursday, June 27, 2024, a trademark application was filed for PLAID RX with the United States Patent and Trademark Office. The USPTO has given the PLAID RX trademark a serial number of 98623330. The federal status of this trademark filing is EXAMINERS AMENDMENT - MAILED as of Tuesday, June 3, 2025. This trademark is owned by Plaid Rx LLC. The PLAID RX trademark is filed in the Advertising, Business and Retail Services category with the following description:

Providing healthcare benefits optimization information to employer self-funded prescription programs for business and cost management purposes, namely, information for use in identifying high cost generic, brand, and specialty prescription drugs and finding alternate ways to reduce or eliminate drug costs; Providing healthcare benefits optimization information for business and cost management purposes, namely, information pertaining to optimizing prescription drug savings, managing the costs associated with pharmaceuticals and drug utilization, and cost management for the health care benefit plans of others
plaid rx

General Information

Serial Number98623330
Word MarkPLAID RX
Filing DateThursday, June 27, 2024
Status647 - EXAMINERS AMENDMENT - MAILED
Status DateTuesday, June 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesProviding healthcare benefits optimization information to employer self-funded prescription programs for business and cost management purposes, namely, information for use in identifying high cost generic, brand, and specialty prescription drugs and finding alternate ways to reduce or eliminate drug costs; Providing healthcare benefits optimization information for business and cost management purposes, namely, information pertaining to optimizing prescription drug savings, managing the costs associated with pharmaceuticals and drug utilization, and cost management for the health care benefit plans of others
NOT AVAILABLE"RX"

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, April 28, 2025
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePlaid Rx LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDallas, TX 75201

Trademark Events

Event DateEvent Description
Thursday, June 27, 2024NEW APPLICATION ENTERED
Wednesday, September 4, 2024TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Wednesday, September 4, 2024TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, January 3, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 3, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 3, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, January 3, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 16, 2025ASSIGNED TO EXAMINER
Friday, January 3, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 14, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 5, 2025EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Wednesday, February 5, 2025COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Wednesday, February 5, 2025NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Wednesday, February 5, 2025EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Friday, February 14, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 14, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 14, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 28, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 28, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 3, 2025EXAMINERS AMENDMENT E-MAILED
Tuesday, June 3, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, June 3, 2025EXAMINER'S AMENDMENT ENTERED
Tuesday, June 3, 2025EXAMINERS AMENDMENT -WRITTEN
Monday, April 28, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED

Related Keywords

plaid cost information prescription drug management healthcare purposes providing costs benefits